Works matching IS 13406868 AND DT 2023 AND VI 30 AND IP 1


Results: 18
    1

    Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies

    Published in:
    Breast Cancer (13406868), 2023, v. 30, n. 1, p. 88, doi. 10.1007/s12282-022-01399-1
    By:
    • Yamamoto, Yutaka;
    • Yamashiro, Hiroyasu;
    • Schneeweiss, Andreas;
    • Müller, Volkmar;
    • Gluz, Oleg;
    • Klare, Peter;
    • Aktas, Bahriye;
    • Magdolna, Dank;
    • Büdi, László;
    • Pikó, Béla;
    • Mangel, László;
    • Toi, Masakazu;
    • Morita, Satoshi;
    • Ohno, Shinji
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy.

    Published in:
    Breast Cancer (13406868), 2023, v. 30, n. 1, p. 131, doi. 10.1007/s12282-022-01406-5
    By:
    • Ohsumi, Shozo;
    • Nishimura, Reiki;
    • Masuda, Norikazu;
    • Akashi-Tanaka, Sadako;
    • Suemasu, Kimito;
    • Yamauchi, Hideko;
    • Tokunaga, Eriko;
    • Ikeda, Tadashi;
    • Nishi, Tsunehiro;
    • Hayashi, Hiroto;
    • Iino, Yuichi;
    • Takatsuka, Yuichi;
    • Ohashi, Yasuo;
    • Inaji, Hideo
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18